269 related articles for article (PubMed ID: 24912658)
1. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain.
Di Stefano G; La Cesa S; Truini A; Cruccu G
J Headache Pain; 2014 Jun; 15(1):34. PubMed ID: 24912658
[TBL] [Abstract][Full Text] [Related]
2. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).
Besi E; Boniface DR; Cregg R; Zakrzewska JM
J Headache Pain; 2015; 16():563. PubMed ID: 26335440
[TBL] [Abstract][Full Text] [Related]
3. Dose dependent enzyme induction by oxcarbazepine?
Patsalos PN; Zakrzewska JM; Elyas AA
Eur J Clin Pharmacol; 1990; 39(2):187-8. PubMed ID: 2253672
[TBL] [Abstract][Full Text] [Related]
4. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia.
Zakrzewska JM; Patsalos PN
Pain; 2002 Feb; 95(3):259-266. PubMed ID: 11839425
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
Lee JE; Min KR; Kim SH; Kim AH; Kim ST
Yonsei Med J; 2020 Oct; 61(10):875-879. PubMed ID: 32975062
[TBL] [Abstract][Full Text] [Related]
6. Real-world effectiveness and tolerability of carbamazepine and oxcarbazepine in 354 patients with trigeminal neuralgia.
Di Stefano G; De Stefano G; Leone C; Di Lionardo A; Di Pietro G; Sgro E; Mollica C; Cruccu G; Truini A
Eur J Pain; 2021 May; 25(5):1064-1071. PubMed ID: 33428801
[TBL] [Abstract][Full Text] [Related]
7. Medical Management of Trigeminal Neuralgia.
Khadilkar SV; Patil VA
Neurol India; 2021; 69(Supplement):S199-S205. PubMed ID: 34003166
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus contributes to carbamazepine resistance in patient with trigeminal neuralgia.
Zhang A; Zhang W; Xu H; Guo C; Yuan L; Xu Y; Ren J; Min L; Sun Q; Lou M; Wei L; Lin S
Neurosurg Rev; 2021 Apr; 44(2):1119-1125. PubMed ID: 32333283
[TBL] [Abstract][Full Text] [Related]
9. European Academy of Neurology guideline on trigeminal neuralgia.
Bendtsen L; Zakrzewska JM; Abbott J; Braschinsky M; Di Stefano G; Donnet A; Eide PK; Leal PRL; Maarbjerg S; May A; Nurmikko T; Obermann M; Jensen TS; Cruccu G
Eur J Neurol; 2019 Jun; 26(6):831-849. PubMed ID: 30860637
[TBL] [Abstract][Full Text] [Related]
10. Effects of Preoperative Carbamazepine Treatment on Microvascular Decompression for Classical Trigeminal Neuralgia.
Song D; Li J; Zhai Y; Yang F; Wang M; Zhao C; Wei X
World Neurosurg; 2021 May; 149():e63-e70. PubMed ID: 33647489
[TBL] [Abstract][Full Text] [Related]
11. Oxcarbazepine for neuropathic pain.
Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
[TBL] [Abstract][Full Text] [Related]
12. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity.
Zakrzewska JM; Ivanyi L
J Allergy Clin Immunol; 1988 Jul; 82(1):110-5. PubMed ID: 3392362
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
[TBL] [Abstract][Full Text] [Related]
14. Patterns of opioid use in patients with trigeminal neuralgia undergoing neurosurgery.
Yang AI; McShane BJ; Hitti FL; Sandhu SK; Chen HI; Lee JYK
J Neurosurg; 2019 Jan; 131(6):1805-1811. PubMed ID: 30641832
[TBL] [Abstract][Full Text] [Related]
15. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options.
Al-Quliti KW
Neurosciences (Riyadh); 2015 Apr; 20(2):107-14. PubMed ID: 25864062
[TBL] [Abstract][Full Text] [Related]
16. Refractory trigeminal neuralgia. Non-surgical treatment options.
Cruccu G; Truini A
CNS Drugs; 2013 Feb; 27(2):91-6. PubMed ID: 23225488
[TBL] [Abstract][Full Text] [Related]
17. AAN-EFNS guidelines on trigeminal neuralgia management.
Cruccu G; Gronseth G; Alksne J; Argoff C; Brainin M; Burchiel K; Nurmikko T; Zakrzewska JM; ;
Eur J Neurol; 2008 Oct; 15(10):1013-28. PubMed ID: 18721143
[TBL] [Abstract][Full Text] [Related]
18. Cranial neuralgias.
Cruccu G; Bonamico LH; Zakrzewska JM
Handb Clin Neurol; 2010; 97():663-78. PubMed ID: 20816462
[TBL] [Abstract][Full Text] [Related]
19. Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
Albani F; Baruzzi A;
Neurol Sci; 2006 Jul; 27(3):173-5. PubMed ID: 16897629
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of betahistine mesilate tablets as augmentation for oxcarbazepine and carbamazepine in treating vestibular paroxysmia.
Xue H; Xiang W; Yu Y; Liu G; Chong Y; Zhou J
Drug Des Devel Ther; 2018; 12():837-843. PubMed ID: 29695895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
